Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2020Bipolar Disorders

A double‐blind, randomized, placebo‐controlled trial of adjunctive blue‐blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder

View Full Paper
Ask AI
Bookmark
Share

Authors

YEYuichi EsakiFujita Health UniversityITIpei TakeuchiSTSoji TsuboiOkazaki City Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Esaki et al. (2020) studied this question.

synapsesocial.com/papers/6a0f3acf89a34af22c6c8f74https://doi.org/10.1111/bdi.12912
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials2015 · 407 citations
  2. 2Comparisons of the Variability of Three Markers of the Human Circadian Pacemaker2002 · 348 citations
  3. 3Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression2000 · 1,189 citations
  4. 4The Use of Exogenous Melatonin in Delayed Sleep Phase Disorder: A Meta-analysis2010 · 268 citations